The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a potential advance. Unlike subcutaneous injections, this method offers a simpler way to deliver GLP-1 https://poppynzdh156466.azzablog.com/41412778/glp-1-patches-a-new-approach-to-blood-sugar-treatment